Cited by 412Treatment of Major DepressionStress Responses and CortisolTryptophan and brain disorders

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Double-blind treatment of major depression with dehydroepiandrosterone.

Wolkowitz, Owen M., Reus, Victor I., Keebler, Audrey, Nelson, Nicola, Friedland, Mirit, Brizendine, Louann, Roberts, Eugene·1999·American Journal of Psychiatry

DOI 10.1176/ajp.156.4.646

Open this paper in CoChat — free account

Abstract

OBJECTIVE: This study was designed to assess possible antidepressant effects of dehydroepiandrosterone (DHEA), an abundant adrenocortical hormone in humans. METHOD: Twenty-two patients with major depression, either medication-free or on stabilized antidepressant regimens, received either DHEA (maximum dose = 90 mg/day) or placebo for 6 weeks in a double-blind manner and were rated at baseline and at the end of the 6 weeks with the Hamilton Depression Rating Scale. Patients previously stabilized with antidepressants had the study medication added to that regimen; others received DHEA or placebo alone. RESULTS: DHEA was associated with a significantly greater decrease in Hamilton depression scale ratings than was placebo. Five of the 11 patients treated with DHEA, compared with none of the 11 given placebo, showed a 50% decrease or greater in depressive symptoms. CONCLUSIONS: These results suggest that DHEA treatment may have significant antidepressant effects in some patients with major depression. Further, larger-scale trials are warranted.

Integrity signals

Registry

Crossref · 10.1176/ajp.156.4.646

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Neurosteroids: Endogenous bimodal modulators of the GABAA receptor mechanism of action and physiological significance
Majewska, M. D. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90025-a · Cited by 1,089
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age [published erratum appears in J Clin Endocrinol Metab 1995 Sep;80(9):2799]
Morales, A. J. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.6.1360 · Cited by 458
Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus.
Monnet, F. P., Mahé, V, Robel, P., & Baulieu, E. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3774 · Cited by 429
Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA).
Kalimi, M., Shafagoj, Y., Loria, R., Padgett, D., & Regelson, W. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00925945 · Cited by 328
Dehydroepiandrosterone (DHEA) treatment of depression
Wolkowitz, O. M., Reus, V. I., Roberts, E., Manfredi, F., Chan, T., Raum, W. J., Ormiston, S., Johnson, R. C., Canick, J., Brizendine, L., et al. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00043-1 · Cited by 314
Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors
Bergeron, R., de Montigny, C., & Debonnel, G. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01193.1996 · Cited by 299
Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study
Berr, C., Lafont, S., Debuire, B., Dartigues, J., & Baulieu, É.-É. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13410 · Cited by 292
Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone
Morley, J. E., Kaiser, F. E., Raum, W. J., Perry, H. M., Flood, J. F., Jensen, J., Silver, A. J., & Roberts, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7537 · Cited by 289

Flagged first, then by citations

Show all 46 references

Research works printed but not linked: 2

Scali G, Nonis E, Petronio G, Casa B: Impiego del dinistile e dell’astenile nelle forme neurastheiche e depressive in geriatria. G Ital Richerche Clin Ter 1980; 85:85–87
Pelliccioni E, Nonis E, Ronchini P, Rizzi C, Scali M: Impiego del deidroandrosterone nelle forme neuroasteniche e depressive in geriatria. G Gerontol 1981; 29:602–603

Sorted by citations

Items 101–200 of 412

DHEA Enhances Emotion Regulation Neurocircuits and Modulates Memory for Emotional Stimuli
Sripada, R. K., Marx, C. E., King, A. P. J., Rajaram, N., Garfinkel, S. N., Abelson, J. L., & Liberzon, I. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.79 · Cited by 85
Dhea Replacement in Women with Adrenal Insufficiency—Pharmacokinetics, Bioconversion and Clinical Effects on Well-Being, Sexuality and Cognition
Arlt, W., Callies, F., & Allolio, B. (2000) · Endocrine Research · doi:10.3109/07435800009048561 · Cited by 85
Dehydroepiandrosterone sulfate (DHEAS) counteracts decremental effects of corticosterone on dentate gyrus LTP. implications for depression
Kaminska, M., Harris, J., Gijsbers, K., & Dubrovsky, B. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00251-3 · Cited by 84
Salivary cortisol and DHEA reactivity to psychosocial stress in socially anxious males
Shirotsuki, K., Izawa, S., Sugaya, N., Yamada, K. C., Ogawa, N., Ouchi, Y., Nagano, Y., & Nomura, S. (2008) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2008.12.010 · Cited by 84
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.
Ravindran, A. V., Lam, R. W., Filteau, M. J., Lespérance, F., Kennedy, S. H., Parikh, S. V., & Patten, S. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.040 · Cited by 108
Antiglucocorticoid drugs in the treatment of depression
Reus, V. I., & Wolkowitz, O. M. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.10.1789 · Cited by 82
Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: A randomized, double-blind placebo controlled trial
Strous, R. D., Stryjer, R., Maayan, R., Gal, G., Viglin, D., Katz, E., Eisner, D., & Weizman, A. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.11.002 · Cited by 80
Off-label use of hormones as an antiaging strategy: a review
Samaras, N., Papadopoulou, M.-A., Samaras, D., & Ongaro, F. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s48918 · Cited by 83
Neurobiology of DHEA and effects on sexuality, mood and cognition
Pluchino, N., Drakopoulos, P., Bianchi‐Demicheli, F., Wenger, J. M., Petignat, P., & Genazzani, A. R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.012 · Cited by 80
Sex hormones and brain aging
Veiga, S. J., Melcangi, R. C., DonCarlos, L. L., García‐Segura, L. M., & Azcoitia, Í. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.05.008 · Cited by 75
Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression
Pucak, M. L., Carroll, K. A. L., Kerr, D. A., & Kaplin, A. L. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.2/mpucak · Cited by 82
Acute and chronic stress increase DHEAS concentrations in rhesus monkeys
Maninger, N., Capitanio, J. P., Mason, W. A., Ruys, J. D., & Mendoza, S. P. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.01.006 · Cited by 76
Analysis of neurosteroid levels in attention deficit hyperactivity disorder
Strous, R. D., Spivak, B., Yoran-Hegesh, R., Maayan, R., Averbuch, E., Kotler, M., Mester, R., & Weizman, A. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002462 · Cited by 75
Hypothalamic–pituitary–adrenocortical system dysregulation and new treatment strategies in depression
Schüle, C., Baghai, T. C., Eser, D., & Rupprecht, R. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.52 · Cited by 74
Compounded Bioidentical Hormones in Endocrinology Practice: An Endocrine Society Scientific Statement
Santoro, N. F., Braunstein, G. D., Butts, C. L., Martin, K. A., McDermott, M., & Pinkerton, J. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1271 · Cited by 75
Steroid secretion in healthy aging
Fiacco, S., Walther, A., & Ehlert, U. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.09.035 · Cited by 71
Salivary cortisol, 17β‐estradiol, progesterone, dehydroepiandrosterone, and α‐amylase in patients with burning mouth syndrome
Kim, H., Kim, Y., Chang, J., Ko, J., & Kho, H. (2012) · Oral Diseases · doi:10.1111/j.1601-0825.2012.01937.x · Cited by 69
Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology
Quiroz, J. A., Singh, J. B., Gould, T. D., Denicoff, K. D., Zarate, C. A., & Manji, H. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001521 · Cited by 71
Cortisol and dehydroepiandrosterone-sulphate levels correlate with symptom severity in first-episode psychosis
Garner, B., Phassouliotis, C., Phillips, L., Markulev, C., Butselaar, F., Bendall, S., Yun, Y., & McGorry, P. D. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.06.008 · Cited by 69
Testosterone and behavior
Morley, J. E. (2003) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(02)00106-4 · Cited by 72
Dehydroepiandrosterone: Is There a Role for Replacement?
Dhatariya, K., & Nair, K. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.10.1257 · Cited by 72
Neuroactive steroids and affective disorders
Eser, D., Schüle, C., Baghai, T. C., Romeo, E., Uzunov, D. P., & Rupprecht, R. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.05.020 · Cited by 69
Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients
Maayan, R., Yagorowski, Y., Grupper, D., Weiss, M., Shtaif, B., Kaoud, M. A., & Weizman, A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00848-9 · Cited by 68
Neurobiology of bipolar disorder
Newberg, A. R., Catapano, L. A., Zarate, C. A., & Manji, H. K. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.1.93 · Cited by 68
Dehydroepiandrosterone and age-related cognitive decline
Sorwell, K. G., & Urbanski, H. F. (2009) · AGE · doi:10.1007/s11357-009-9113-4 · Cited by 66
Improvement of Sustained Attention and Visual and Movement Skills, but Not Clinical Symptoms, After Dehydroepiandrosterone Augmentation in Schizophrenia
Ritsner, M. S., Gibel, A., Ratner, Y., Tsinovoy, G., & Strous, R. D. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000237942.50270.35 · Cited by 66
Neurosteroids and neuroactive drugs in mental disorders
Pisu, M. G., & Serra, M. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.12.002 · Cited by 66
Uses of DHEA in aging and other disease states
JOHNSON, M., Bebb, R. A., & Sirrs, S. M. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00369-4 · Cited by 66
The risk of affective disorders in patients with adrenocortical insufficiency
Thomsen, A. F., Kvist, T. K., Andersen, P. K., & Kessing, L. V. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.01.003 · Cited by 79
Neurosteroid modulation of embryonic neuronal survival in vitro following anoxia
Marx, C. E., Jarskog, L. F., Lauder, J. M., Gilmore, J. H., Lieberman, J. A., & Morrow, A. L. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02452-5 · Cited by 65
Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement.
Brooke, A., Kalingag, L. A., Miraki-Moud, F., Camacho-Hübner, C., Maher, K., Walker, D., Hinson, J., & Monson, J. (2006) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2006-0316 · Cited by 61
Dehydroepiandrosterone upregulates neural androgen receptor level and transcriptional activity.
Lu, S.-F., Mo, Q., Hu, S., Garippa, C., & Simon, N. G. (2003) · Journal of Neurobiology · doi:10.1002/neu.10260 · Cited by 66
Predictors of lapse in first week of smoking abstinence in PTSD and non-PTSD smokers
Beckham, J. C., Calhoun, P. S., Dennis, M. F., Wilson, S. M., & Dedert, E. A. (2013) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts252 · Cited by 61
Pregnenolone sulfate as a modulator of synaptic plasticity
Smith, C. C., Gibbs, T. T., & Farb, D. H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3643-x · Cited by 58
Stress Response Modulation Underlying the Psychobiology of Resilience
Averill, L. A., Averill, C. L., Kelmendi, B., Abdallah, C. G., & Southwick, S. M. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0887-x · Cited by 64
The Relevance of Neuroactive Steroids in Schizophrenia, Depression, and Anxiety Disorders
MacKenzie, E. M., Odontiadis, J., Mellédo, J. L., Prior, T. I., & Baker, G. B. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9086-0 · Cited by 61
Exclusion Criteria Used in Antidepressant Efficacy Trials: Consistency Across Studies and Representativeness of Samples Included
Zimmerman, M., Chelminski, I., & Posternak, M. A. (2004) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000110279.23893.82 · Cited by 58
DHEA Lessens Depressive-Like Behavior via GABA-ergic Modulation of the Mesolimbic System
Genud, R., Merenlender, A., Gispan-Herman, I., Maayan, R., Weizman, A., & Yadid, G. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.46 · Cited by 55
Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits.
Marić, N. P., & Adžić, M. (2013) · PubMed · Cited by 56
Neuroactive steroids as modulators of depression and anxiety
Eser, D., Romeo, E., Baghai, T. C., di Michele, F., Schüle, C., Pasini, A., Zwanzger, P., Padberg, F., & Rupprecht, R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.007 · Cited by 54
Drug treatment of depression in the 2000s: an overview of achievements in the last 10 years and future possibilities
Baghai, T. C., Volz, H., & Möller, H. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970601003973 · Cited by 53
Future Antidepressants
Bosker, F. J., Westerink, B. H. C., Cremers, T. I. F. H., Gerrits, M., van der Hart, M. G. C., Kuipers, S. D., van der Pompe, G., Horst, G. J. T., den Boer, J. A., & Korf, J. (2004) · CNS Drugs · doi:10.2165/00023210-200418110-00002 · Cited by 55
Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations
Heinz, A., Weingartner, H., George, D., Hommer, D. W., Wolkowitz, O. M., & Linnoila, M. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00099-2 · Cited by 52
Human Brain Slice Culture: A Useful Tool to Study Brain Disorders and Potential Therapeutic Compounds
Qi, X., Verwer, R. W. H., Bao, A., Balesar, R. A., Luchetti, S., Zhou, J., & Swaab, D. F. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-018-0328-1 · Cited by 51
Reproductive Aging, Sex Steroids, and Mood Disorders
Harsh, V., Meltzer-Brody, S. E., Rubinow, D. R., & Schmidt, P. J. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902891877 · Cited by 50
Eating disorders: a review of the literature with emphasis on medical complications and clinical nutrition.
Patrick, L. (2002) · PubMed · Cited by 52
Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers
Marx, C. E., Trost, W. T., Shampine, L. J., Behm, F. M., Giordano, L. A., Massing, M. W., & Rose, J. E. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0226-x · Cited by 51
Dehydroepiandrosterone replacement in patients with Addison's disease has a bimodal effect on regulatory (CD4+CD25hi and CD4+FoxP3+) T cells
Coles, A. J., Thompson, S. A. J., Cox, A., Curran, S., Gurnell, E. M., & Chatterjee, V. K. (2005) · European Journal of Immunology · doi:10.1002/eji.200526128 · Cited by 51
Dehydroepiandrosterone replacement therapy.
Gurnell, E. M., & Chatterjee, V. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450103 · Cited by 78
Symptom Severity and Exclusion From Antidepressant Efficacy Trials
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00011 · Cited by 49
Salivary dehydroepiandrosterone, but not cortisol, is associated with attention deficit hyperactivity disorder
Wang, L., Huang, Y., Hsiao, C.-C., Chiang, Y.-L., Wu, C., Shang, Z.-Y., & Chen, C. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.512090 · Cited by 52
Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls
Kurita, H., Maeshima, H., Kida, S., Matsuzaka, H., Shimano, T., Nakano, Y., Baba, H., Suzuki, T., & Arai, H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.09.004 · Cited by 48
Neuroactive Steroids in Depression and Anxiety Disorders: Clinical Studies
Eser, D., Schüle, C., Baghai, T. C., Romeo, E., & Rupprecht, R. (2006) · Neuroendocrinology · doi:10.1159/000097879 · Cited by 49
Natural health products, dietary minerals and over-the-counter medications as add-on therapies to antidepressants in the treatment of major depressive disorder: a review
Döme, P., Tombor, L., Lazáry, J., Gonda, X., & Rihmer, Z. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.015 · Cited by 49
Influence of Sleep Deprivation on Neuroactive Steroids in Major Depression
Schüle, C., di Michele, F., Baghai, T. C., Romeo, E., Bernardi, G., Zwanzger, P., Padberg, F., Pasini, A., & Rupprecht, R. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300084 · Cited by 48
Three-Month Treatment Course of Methylphenidate Increases Plasma Levels of Dehydroepiandrosterone (DHEA) and Dehydroepiandrosterone-Sulfate (DHEA-S) in Attention Deficit Hyperactivity Disorder
Maayan, R., Yoran‐Hegesh, R., Strous, R. D., Nechmad, A., Averbuch, E., Weizman, A., & Spivak, B. (2003) · Neuropsychobiology · doi:10.1159/000073626 · Cited by 47
Dehydroepiandrosterone (DHEA) and the Aging Brain: Flipping a Coin in the “Fountain of Youth”
Racchi, M., Balduzzi, C., & Corsini, E. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00242.x · Cited by 47
A Critical Overview of the Pharmacologic Management of Treatment-Resistant Depression
Nierenberg, A. A., Katz, J., & D, M. F. M. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.01.001 · Cited by 48
Dehydroepiandrosterone sulfate (DHEAS) and health: does the relationship differ by sex?
Glei, D. A., Goldman, N., Weinstein, M., & Liu, I.-W. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.11.003 · Cited by 46
The Neurobiology of the Stress Cascade and Its Potential Relevance for Schizophrenia
Corcoran, C. M., Gallitano, A. L., Leitman, D., & Malaspina, D. (2001) · Journal of Psychiatric Practice · doi:10.1097/00131746-200101000-00002 · Cited by 45
Salivary dehydroepiandrosterone (DHEA) levels in patients with the complaint of burning mouth: a case-control study
Fernandes, C. S. D., Salum, F. G., Bandeira, D. R., Pawlowski, J., Luz, C., & Cherubini, K. (2009) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2009.06.022 · Cited by 43
The psychobiology of resilience and vulnerability to anxiety disorders: implications for prevention and treatment
Charney, D. S. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.3/dcharney · Cited by 42
Basal cortisol and DHEA levels in women with borderline personality disorder
Jogems-Kosterman, B. J. M., de Knijff, D. W. W., Kusters, R., & van Hoof, J. J. M. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.019 · Cited by 55
Missing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and Microglia
Kato, T. A., Hayakawa, K., Monji, A., & Kanba, S. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00053 · Cited by 43
Nonhuman Primate Models of Cognitive Aging
Agnès Lacreuse, A., & Herndon, J. G. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-422-3_2 · Cited by 42
The Influence of Hormones and Pharmaceutical Agents on DHEA and DHEA‐S Concentrations: A Review of Clinical Studies
Salek, F. S., Bigos, K. L., & Kroboth, P. D. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/00912700222011274 · Cited by 40
Circulating levels of neuroactive steroids in patients with binge eating disorder: A comparison with nonobese healthy controls and non‐binge eating obese subjects
Monteleone, P., Luisi, M., Filippis, G. D., Colurcio, B., Monteleone, P., Genazzani, A. R., & Maj, M. (2003) · International Journal of Eating Disorders · doi:10.1002/eat.10199 · Cited by 41
Prasterone (DHEA) and Mania
Dean, C. E. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.10115 · Cited by 41
Adolescent depression, cortisol and DHEA
Angold, A. C. (2003) · Psychological Medicine · doi:10.1017/s003329170300775x · Cited by 41
The specificity of stress responses to different nocuous stimuli: neurosteroids and depression
Dubrovsky, B. O. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00269-5 · Cited by 40
Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders
Eser, D., Schüle, C., Romeo, E., Baghai, T. C., di Michele, F., Pasini, A., Zwanzger, P., Padberg, F., & Rupprecht, R. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0188-z · Cited by 39
Anxiety, depression, and insomnia
Larzelere, M., & Wiseman, P. (2002) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(01)00003-3 · Cited by 39
Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
Cleare, A., O'Keane, V., & Miell, J. (2004) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00104-5 · Cited by 39
Effects of dehydroepiandrosterone supplementation during stressful military training: A randomized, controlled, double-blind field study
Taylor, M. K., Padilla, G. A., Stanfill, K. E., Markham, A. E., Khosravi, J. Y., Dial Ward, M. D., & Koehler, M. M. (2012) · Stress · doi:10.3109/10253890.2011.585189 · Cited by 38
Association of DHEA, DHEAS, and cortisol with childhood trauma exposure and post-traumatic stress disorder
Voorhees, E. E. V., Dennis, M. F., Calhoun, P. S., & Beckham, J. C. (2013) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328364ecd1 · Cited by 39
The Use of Dehydroepiandrosterone Therapy in Clinical Practice
Cameron, D. R., & Braunstein, G. D. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504020-00004 · Cited by 38
Alterations in the steroid biosynthetic pathways in the human prefrontal cortex in mood disorders: A post‐mortem study
Qi, X., Luchetti, S., Verwer, R. W. H., Sluiter, A. A., Mason, M. R. J., Zhou, J., & Swaab, D. F. (2017) · Brain Pathology · doi:10.1111/bpa.12548 · Cited by 34
Chronic fatigue syndrome: a systematic review
Maquet, D., Demoulin, C., & Crielaard, J.-M. (2006) · Annales de Réadaptation et de Médecine Physique · doi:10.1016/j.annrmp.2006.04.001 · Cited by 36
Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin
Tait, G. R., McManus, K., Bellavance, F., Lara, N., Chrapko, W. E., & Mellédo, J. L. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00051-8 · Cited by 36
The protective effect of frontal cortex dehydroepiandrosterone in anxiety and depressive models in mice
Maayan, R., Touati-Werner, D., Ram, E., Strous, R. D., Keren, O., & Weizman, A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.010 · Cited by 36
Antiglucocoticoid Treatments for Depression
Young, A. H. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01813.x · Cited by 36
Higher DHEA-S (dehydroepiandrosterone sulfate) levels are associated with depressive symptoms during the menopausal transition: results from the PENN Ovarian Aging Study
Morrison, M. F., Freeman, E. W., Lin, H., & Sammel, M. D. (2011) · Archives of Women s Mental Health · doi:10.1007/s00737-011-0231-5 · Cited by 36
Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind controlled pilot study
Dias, R. D. S., Kerr-Corrêa, F., Moreno, R. A., Trinca, L. A., Pontes, A., Halbe, H. W., Gianfaldoni, A., & Dalben, I. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000198491.34371.9c · Cited by 33
The involvement of dehydroepiandrosterone (DHEA) and its sulfate ester (DHEAS) in blocking the therapeutic effect of electroconvulsive shocks in an animal model of depression
Maayan, R., Morad, O., Dorfman-Etrog, P., Overstreet, D. H., Weizman, A., & Yadid, G. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.10.005 · Cited by 35
A decrease in the plasma DHEA to cortisol ratio during smoking abstinence may predict relapse: a preliminary study
Rasmusson, A. M., Wu, R., Paliwal, P., Anderson, G. M., & Krishnan‐Sarin, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0367-6 · Cited by 33
Dehydroepiandrosterone (DHEA) for Depression: A Systematic Review and Meta-Analysis
Peixoto, C., Grande, A. J., Mallmann, M. B., Nardi, A. E., Cardoso, A., & Veras, A. B. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180817153914 · Cited by 33
Dehydroepiandrosterone for Adrenal Insufficiency
Oelkers, W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411409 · Cited by 32
Aging of the hypothalamic-pituitary-adrenal axis in nonhuman primates with depression-like and aggressive behavior
Goncharova, N. D., Marenin, V. Y., & Oganyan, T. E. (2010) · Aging · doi:10.18632/aging.100227 · Cited by 31
Neurosteroids in child and adolescent psychopathology
Golubchik, P., LEWIS, M., Maayan, R., Sever, J. M., Strous, R. D., & Weizman, A. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.08.003 · Cited by 31
Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease
Masera, R. G., Prolo, P., Sartori, M. L., Staurenghi, A., Griot, G., Ravizza, L., Dovio, A., Chiappelli, F., & Angeli, A. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00062-2 · Cited by 31
Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression
Hough, C. M., Lindqvist, D., Epel, E. S., Denis, M. S., Reus, V. I., Bersani, F. S., Rosser, R., Mahan, L., Burke, H. M., Wolkowitz, O. M., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.035 · Cited by 30
Antidepressant efficacy screening of novel targets in the chick anxiety-depression model
Sufka, K. J., Warnick, J. E., Pulaski, C. N., Slauson, S. R., Kim, Y. B., & Rimoldi, J. M. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32832a8082 · Cited by 30
Effect of fluoxetine on blood concentrations of serotonin, cortisol and dehydroepiandrosterone in canine aggression
Rosado, B., García‐Belenguer, S., León, M., Chacón, G., Villegas, A., & Palacio, J. (2010) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2010.01254.x · Cited by 29
Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression
Hsiao, C. (2006) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.03.008 · Cited by 29
Crossroads of corticotropin releasing hormone, corticosteroids and monoamines
van Praag, H. M. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000022115 · Cited by 29
Potentiation strategies for treatment‐resistant depression
Ros, S., Agüera, L., de la Gándara, J., Rojo, E., & de Pedro, J. M. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00676.x · Cited by 29
Dehydroepiandrosterone (DHEA) Effects on HIV Replication and Host Immunity: A Randomized Placebo-Controlled Study
Abrams, D. I., Shade, S. B., Couey, P., McCune, J. M., Lo, J. C.-M., Bacchetti, P., CHANG, B. C. F., Epling, L., Liegler, T. J., & Grant, R. M. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0107 · Cited by 29
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
Henter, I. D., SOUSA, R. T. D., Gold, P. W., Brunoni, A. R., Zarate, C. A., & Machado‐Vieira, R. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1253472 · Cited by 29
Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients
Schüle, C., Baghai, T. C., Eser, D., Schwarz, M., Bondy, B., & Rupprecht, R. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.07.003 · Cited by 28
The antidepressant-like effects of the 3β-hydroxysteroid dehydrogenase inhibitor trilostane in mice is related to changes in neuroactive steroid and monoamine levels
Espallergues, J., Mamiya, T., Vallée, M., Koseki, T., Nabeshima, T., Temsamani, J., Laruelle, C., & Maurice, T. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.005 · Cited by 30

Authors: Wolkowitz, O. M., Reus, V. I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., & Roberts, E.
Affiliations: University of California, San Francisco (US)
ORCID: Wolkowitz, Owen M.
Reus, Victor I.
Venue: American Journal of Psychiatry
Publisher: American Psychiatric Association Publishing
Published: 1999-04-01
Volume: 156
Issue: 4
Pages: 646-649
ISSN: 0002-953X (ISSN-L)
1535-7228
DOI: 10.1176/ajp.156.4.646
OpenAlex: W1922088893
Cited by: 411
References: 46
Citations by year: 2026: 2 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 2 · 2021: 4 · 2020: 9 · 2019: 7 · 2018: 12 · 2017: 8 · 2016: 10 · 2015: 9 · 2014: 17 · 2013: 20 · 2012: 17
FWCI: 13.69
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords: dehydroepiandrosterone, major depressive disorder, antidepressant effects, adrenal cortex hormones, Hamilton Depression Rating Scale, adjunctive therapy
MeSH terms: Adult, Antidepressive Agents, Dehydroepiandrosterone, Depressive Disorder, Double-Blind Method, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Placebos, Psychiatric Status Rating Scales, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Double-blind treatment of major depression with dehydroepiandrosterone.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks